United States · FDA National Drug Code directory
PRESIGEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84761-0003_4710495d-4199-d77e-e063-6394a90ab9b9
- Product NDC
- 84761-0003
- Form
- CAPSULE
- Composition / generic term
- PRESIGEN
- Labeler
- Tejeda Enterprises Incorporated
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20241001
- Source listing expiry
- 20261231
Source-listed ingredients
- ALLIUM SATIVUM WHOLE — 2000 mg/2U
- MOMORDICA CHARANTIA STEM — 740 mg/2U
These values do not establish equivalence or a dose recommendation.
Packages
- 60 U in 1 PACKAGE (84761-0003-2) · 84761-0003-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →